Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Transpl Infect Dis ; 18(1): 98-104, 2016 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-26460906

RESUMO

Norovirus is a major cause of self-limited gastroenteritis worldwide. Prevention and treatment are thwarted by rapid viral evolution, and thus supportive care remains the mainstay of therapy. Chronic infection in immunocompromised hosts is increasingly described. We report a case of norovirus infection lasting 2543 days in a pancreas transplant recipient. Serial fecal specimens were obtained, from which a map of genetic relatedness was derived. The clinical course was complicated by renal failure that progressed to end-stage renal disease. Minimization of immunosuppression was associated with resolution of the infection. Subsequently, the patient experienced a suspected allograft rejection that did not compromise pancreas function. The patient later underwent living-related renal transplantation without recurrence of enteritis.


Assuntos
Infecções por Caliciviridae/virologia , Gastroenterite/virologia , Falência Renal Crônica/complicações , Norovirus/isolamento & purificação , Transplante de Pâncreas/efeitos adversos , Infecções por Caliciviridae/complicações , Doença Crônica , Feminino , Gastroenterite/complicações , Rejeição de Enxerto , Humanos , Hospedeiro Imunocomprometido , Terapia de Imunossupressão/efeitos adversos , Pessoa de Meia-Idade , Norovirus/genética
2.
Transpl Infect Dis ; 12(1): 87-93, 2010 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-19735384

RESUMO

Multi-drug resistant (MDR) gram-negative infections among solid organ transplant (SOT) recipients have long been associated with high morbidity and mortality. Acinetobacter baumannii has emerged as a potent nosocomial pathogen with the recent acquisition of resistance to broad-spectrum beta-lactams, aminoglycosides, fluoroquinolones, and most notably, carbapenems. Despite a national rise in carbapenem-resistant A. baumannii (CRAB) infections, outcomes among SOT recipients with this emerging MDR pathogen are largely unknown. This single-center cohort is the first to describe the characteristics, complications, and outcomes among abdominal organ transplant recipients with CRAB. The current study suggests that SOT patients with CRAB suffer from prolonged hospitalization, infection with other MDR organisms, allograft dysfunction and loss, and high overall infection-related mortality.


Assuntos
Infecções por Acinetobacter/microbiologia , Acinetobacter baumannii/efeitos dos fármacos , Antibacterianos/farmacologia , Carbapenêmicos/farmacologia , Transplante de Órgãos/efeitos adversos , Resistência beta-Lactâmica , Infecções por Acinetobacter/diagnóstico , Infecções por Acinetobacter/mortalidade , Adulto , Idoso , Feminino , Humanos , Transplante de Rim/efeitos adversos , Transplante de Fígado/efeitos adversos , Masculino , Pessoa de Meia-Idade
4.
Transpl Infect Dis ; 6(2): 77-80, 2004 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-15522109

RESUMO

This report describes the clinical course of a liver transplant recipient in whom cavitary pneumonia developed due to Legionella pneumophila. We review the experience with cavitary pulmonary processes caused by Legionella species in liver allograft recipients and describe the diagnostic microbiology of this organism. The clinical course of this patient demonstrates the importance of considering legionellosis in the differential diagnosis of lung abscesses after liver transplantation and the diagnostic difficulties encountered with this bacterium.


Assuntos
Legionella pneumophila/isolamento & purificação , Doença dos Legionários/microbiologia , Transplante de Fígado/efeitos adversos , Abscesso Pulmonar/microbiologia , Adulto , Feminino , Humanos , Doença dos Legionários/diagnóstico , Abscesso Pulmonar/diagnóstico , Transplante Homólogo/efeitos adversos
5.
Arch Intern Med ; 160(18): 2819-22, 2000 Oct 09.
Artigo em Inglês | MEDLINE | ID: mdl-11025792

RESUMO

BACKGROUND: The development of antimicrobial guidelines is one way in which institutions attempt to control emerging resistance, but the real challenge falls on promoting and ensuring adherence to these guidelines. Investigating reasons for the prescribing of alternative antimicrobial agents outside of these guidelines is crucial for modifying practices that may adversely impact institutional antimicrobial goals. METHODS: Retrospective cross-referencing of computerized pharmacy printouts and concurrent manual medical record review. RESULTS: Approximately 25% (470/1893) of the patients requiring antimicrobial therapy reported an allergy to at least 1 antimicrobial agent. The most commonly reported antimicrobial allergy was penicillin (295/1893 [15.6%]). Eighty-five patients (18.1%) reported having an allergy to 2 or more antimicrobial agents. Only 4% (27/601) of the reported antimicrobial allergies contained documentation as to the nature of the specific allergic reactions, while a manual medical record review revealed that 32% (23/73) of the antimicrobial allergies contained documentation of the specific allergic reaction. Ninety-eight (39. 7%) of 247 patients reporting an allergy only to penicillin and/or cephalosporin received vancomycin in comparison with 247 (17.4%) of 1423 patients without any antimicrobial allergies (P<.001). Similarly, 53 (21.5%) of 247 patients with reported penicillin and/or cephalosporin allergies received levofloxacin compared with 114 (8.0%) of 1423 patients without any antimicrobial allergy (P<. 001). CONCLUSION: The incidence of penicillin allergy at our institution exceeds population averages. This finding, in combination with limited documentation of drug allergies, appears to lead to the prescribing of alternative antimicrobial agents that do not fit into institutional antimicrobial guidelines and, in some instances, may put the patient at risk for infection and/or colonization with resistant organisms. Use of these alternative agents may adversely impact the ability to manage emerging antimicrobial resistance.


Assuntos
Antibacterianos/efeitos adversos , Hipersensibilidade a Drogas/epidemiologia , Resistência Microbiana a Medicamentos , Hospitalização/estatística & dados numéricos , Antibacterianos/uso terapêutico , Chicago/epidemiologia , Estudos Transversais , Hipersensibilidade a Drogas/etiologia , Registros Hospitalares , Humanos , Incidência , Guias de Prática Clínica como Assunto , Estudos Retrospectivos , Fatores de Risco
6.
Int J Antimicrob Agents ; 10(2): 95-105, 1998 May.
Artigo em Inglês | MEDLINE | ID: mdl-9716286

RESUMO

As the problem of global antibiotic resistance continues to worsen, aminoglycosides have assumed increasing importance in clinical practice. Their broad antimicrobial spectrum, rapid bactericidal action, and ability to act synergistically with other drugs have made them especially useful in the treatment of serious nosocomial infections. However, as with other drugs, their overuse and misuse leads to the development of resistance in important microbial pathogens. The appropriate use of the aminoglycosides is essential to assure their continued efficacy. Therefore, physicians must familiarize themselves with both the clinical indications and the limitations of these drugs if they are to remain efficacious in the years to come.


Assuntos
Antibacterianos/uso terapêutico , Aminoglicosídeos , Antibacterianos/efeitos adversos , Antibacterianos/química , Antibacterianos/farmacologia , Infecção Hospitalar/tratamento farmacológico , Antagonismo de Drogas , Resistência Microbiana a Medicamentos , Sinergismo Farmacológico , Quimioterapia Combinada/uso terapêutico , Humanos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA